Trial · NCT03156621
Outcomes23
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
1 to 20 of 23
Download this page as JSON| Type | Outcome | Time frame | Population | Units | Measured as |
|---|---|---|---|---|---|
| PRIMARY | Percent Change in Low-density Lipoprotein Cholesterol (LDL-C) From Baseline to Week 12 (Intent-to-Treat [ITT] Estimand) | Baseline to Week 12 | ITT estimand (All randomized participants who had at least 1 measurement value for LDL-C before the first dose of double blind investigational study drug) | Percentage of change | LEAST_SQUARES_MEAN |
| SECONDARY | Percent Change in Apolipoprotein (Apo) B From Baseline to Week 12 (ITT Estimand) | Baseline to Week 12 | Percentage of change | LEAST_SQUARES_MEAN | |
| SECONDARY | Percent Change in Non-high-density Lipoprotein Cholesterol (Non-HDL-C) From Baseline to Week 12 | Baseline to Week 12 | Percentage of change | LEAST_SQUARES_MEAN | |
| SECONDARY | Percent Change in Total Cholesterol (TC) From Baseline to Week 12 | Baseline to Week 12 | Percentage of change | LEAST_SQUARES_MEAN | |
| SECONDARY | Percentage of Participants With ≥15% Reduction in LDL-C at Week 12 | At Week 12 | Percentage of participants | NUMBER | |
| SECONDARY | Percentage of Participants With ≥30% Reduction in LDL-C at Week 12 | At Week 12 | Percentage of participants | NUMBER | |
| SECONDARY | Percent Change in Lipoprotein(a) [Lp(a)] From Baseline to Week 12 | Baseline to Week 12 | Percentage of change | LEAST_SQUARES_MEAN | |
| SECONDARY | Percentage of Participants With ≥50% Reduction in LDL-C at Week 12 | At Week 12 | Percentage of participants | NUMBER | |
| SECONDARY | Percent Change in HDL-C From Baseline to Week 12 - ITT Analysis | Baseline to Week 12 | Percentage of change | LEAST_SQUARES_MEAN | |
| SECONDARY | Percent Change in Fasting Triglycerides (TG) From Baseline to Week 12 | Baseline to Week 12 | Percentage of change | LEAST_SQUARES_MEAN | |
| SECONDARY | Percent Change in Apo A-1 From Baseline to Week 12 -- ITT Analysis | Baseline to Week 12 | Percentage of change | LEAST_SQUARES_MEAN | |
| SECONDARY | Percent Change in LDL-C From Baseline to Week 12 (On-treatment Estimand) | Baseline to Week 12 | Percentage of change | LEAST_SQUARES_MEAN | |
| SECONDARY | Percent Change in Apo B From Baseline to Week 12 (On-treatment Estimand) | Baseline to Week 12 | Percentage of change | LEAST_SQUARES_MEAN | |
| SECONDARY | Percent Change in Non-HDL-C From Baseline to Week 12 (On-treatment Estimand) | Baseline to Week 12 | Percentage of change | LEAST_SQUARES_MEAN | |
| SECONDARY | Percent Change in TC From Baseline to Week 12 (On-treatment Estimand) | Baseline to Week 12 | Percentage of change | LEAST_SQUARES_MEAN | |
| SECONDARY | Percent Change in Lp(a) From Baseline to Week 12 (On-treatment Estimand) | Baseline to Week 12 | Percentage of change | LEAST_SQUARES_MEAN | |
| SECONDARY | Percent Change in HDL-C From Baseline to Week 12 (On-treatment Estimand) | Baseline to Week 12 | Percentage of change | LEAST_SQUARES_MEAN | |
| SECONDARY | Percent Change in Fasting TG From Baseline to Week 12 (On-treatment Estimand) | Baseline to Week 12 | Percentage of change | LEAST_SQUARES_MEAN | |
| SECONDARY | Percent Change in Apo A-1 From Baseline to Week 12 (On-treatment Estimand) | Baseline to Week 12 | Percentage of change | LEAST_SQUARES_MEAN | |
| SECONDARY | Percentage of Participants With ≥15% Reduction, ≥30% Reduction, and ≥50% Reduction in LDL-C at Week 12 (On-treatment Estimand) | At Week 12 | Percentage of participants | NUMBER |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03156621/outcomes